Despite a number of practical benefits for patients and having comparable detection rates to conventional colonoscopy for colorectal cancer, computed tomography colonography (CTC) remains significantly underutilized. In fact, a recently published survey of over 13,700 people between the ages of 50 to 75 found that 

only 1.4 percent of respondents had CTC for colorectal cancer screening

Various authors have pointed to the lack of Medicare coverage as a key factor in the limited access and use of CTC. Noting the potential impact CTC could have in improving colorectal cancer screening rates in at-risk populations, the 

American College of Radiology recently wrote a formal request to the Centers for Medicare and Medicaid Services (CMS)

, urging the organization to reconsider non-coverage of CTC for Medicare and Medicaid beneficiaries.

With this in mind, Syam Reddy, MD, Judy Yee, MD and Anand Narayan, MD, recently spoke with 

 to discuss the benefits of CTC, limitations of access to the procedure and suggested steps for potentially resolving this issue.

News

 CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Oncology CT

Women's Health CT

In recent video interviews, Syam Reddy, MD, Judy Yee, MD and Anand Narayan, MD, discussed various benefits of computed tomography colonography (CTC) for colorectal cancer screening, the underutilization of the CTC procedure and steps moving forward to improve access to this procedure.

Emerging Perspectives on Computed Tomography Colonography